Opko Health (OPK) Raw Materials (2019 - 2026)

Opko Health has reported Raw Materials for 8 years, with the latest figure at $11.1 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials rose 1.5% year-over-year to $11.1 million; the trailing twelve-month figure through Mar 2026 stood at $11.1 million (up 1.5% YoY), and the FY2025 full-year result was $13.1 million, up 38.99% from the prior year.
• Raw Materials for Q1 2026 stood at $11.1 million, down from $13.1 million in the prior quarter.
• The five-year high for Raw Materials was $29.3 million in Q2 2023, with the low at $6.8 million in Q4 2022.
• Historically, Raw Materials has averaged $12.7 million across 5 years, with a median of $11.0 million in 2025.
• The largest YoY upside for Raw Materials was 152.2% in 2024 against a maximum downside of 68.39% in 2024.
• Opko Health's Raw Materials stood at $6.8 million in 2022, then surged by 32.64% to $9.0 million in 2023, then increased by 4.87% to $9.4 million in 2024, then surged by 38.99% to $13.1 million in 2025, then dropped by 15.14% to $11.1 million in 2026.
• The last three Raw Materials figures came in at $11.1 million (Q1 2026), $13.1 million (Q4 2025), and $13.0 million (Q3 2025), per Business Quant data.